Evidence map›Paper›PMID 33858822›Full record

ArticleAJNR. American journal of neuroradiology2021

Optimal Duration of MRI Follow-up to Safely Identify Middle Ear Residual Cholesteatoma.

A-L Fourez, M Akkari, G Gascou, P-H Lefevre, C Duflos, A Kaderbay, M Mondain, F Venail

Open access · hybridAbstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Evaluation of the effectiveness of bone obliteration in cholesteatoma surgery.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

A-L FourezFrom the Departments of ENT and Head and Neck Surgery (A.-L.F., M.A., A.K., M.M., F.V.).ORCID 0000-0002-1278-926X
M AkkariFrom the Departments of ENT and Head and Neck Surgery (A.-L.F., M.A., A.K., M.M., F.V.).ORCID 0000-0003-2408-4133
G GascouNeuroradiology (G.G., P.-H.L.), University Hospital Gui de Chauliac.ORCID 0000-0002-0817-7324
P-H LefevreNeuroradiology (G.G., P.-H.L.), University Hospital Gui de Chauliac.ORCID 0000-0002-6196-3869
C DuflosDepartment of Medical Information and Biostatistics (C.D.), University Hospital La Colombière, University of Montpellier, Montpellier, France.ORCID 0000-0002-7239-530X
A KaderbayFrom the Departments of ENT and Head and Neck Surgery (A.-L.F., M.A., A.K., M.M., F.V.).ORCID 0000-0001-7489-2994
M MondainFrom the Departments of ENT and Head and Neck Surgery (A.-L.F., M.A., A.K., M.M., F.V.).ORCID 0000-0001-7785-9735
F VenailFrom the Departments of ENT and Head and Neck Surgery (A.-L.F., M.A., A.K., M.M., F.V.) f-venail@chu-montpellier.fr.ORCID 0000-0001-9919-2126
MACOM (United States) · USCentre Hospitalier Universitaire de Montpellier · FRInserm · FRZhejiang A & F University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposePrevious studies have demonstrated the usefulness of non-EPI DWI for detection of residual cholesteatoma. However, limited data are available to determine the suitable duration of imaging follow-up after a first MR imaging with normal findings has been obtained. The present study aimed to determine the optimal duration of non-EPI DWI follow-up for residual cholesteatoma. MATERIALS AND

methodsA retrospective, monocentric study was performed between 2013 and 2019 and included all participants followed up after canal wall up tympanoplasty with at least 2 non-EPI DWI examinations performed on the same 1.5T MR imaging scanner. MR images were reviewed independently by 2 radiologists. Sensitivity and specificity values were calculated as a function of time after the operation. Receiver operating characteristic curves were analyzed to determine the optimal follow-up duration.

resultsWe analyzed 47 MRIs from 17 participants. At the end of the individual follow-up period, a residual cholesteatoma had been found in 41.1% of cases. The follow-up duration ranged from 20 to 198 months (mean, 65.9 [SD, 43.9] months). Participants underwent between 2 and 5 non-EPI DWI examinations. Analyses of the receiver operating characteristic curves revealed that the optimal diagnostic value of non-EPI DWI occurred 56 months after the operation when the first MR imaging performed a mean of 17.3 (SD, 6.8) months after the operation had normal findings (sensitivity = 0.71; specificity = 0.7, Youden index = 0.43).

conclusionsRepeat non-EPI DWI is required to detect slow-growing middle ear residual cholesteatomas. We, therefore, recommend performing non-EPI DWI for at least the first 5 years after the initial operation.

Indexed as

Cholesteatoma, Middle EarAdolescentAdultAgedChildDiffusion Magnetic Resonance ImagingEar, MiddleFemaleFollow-Up StudiesHumansMagnetic Resonance ImagingMaleMiddle AgedRetrospective StudiesSensitivity and SpecificityYoung Adult

Identifiers

PMID33858822
PMCPMC8324276
OpenAlexW3155252657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.